Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism BTK inhibitors(Tyrosine-protein kinase BTK inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC26H23FN8O2 |
InChIKeyRQYDQAPLARKISN-UHFFFAOYSA-N |
CAS Registry1646608-10-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Phase 1 | - | - |